| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |